Home | Welcome to Contract Pharma   
Last Updated Thursday, July 31 2014
Print

Search Results for 'fda'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published June 26, 2013
Wolfratshausen facility supports dosage forms for U.S. distribution Read More »
By Colleen Heisey, J.D., M.P.H., Hunton & Williams LLP
Published January 22, 2013
FDA revises draft guidance document to address industry comments Read More »
Published October 8, 2012
Reviewed systems, processes and procedures, with no Form 483 observations Read More »
By Gil Roth
Published July 31, 2012
No 483s at Clinical Pharmacology Unit Read More »
By Gil Roth
Published June 25, 2012
First U.S.-based packaging facility to handle CV, metabolic drugs Read More »
Published April 25, 2012
FDA to accept some studies, require reanalysis for others Read More »
By Gil Roth
Published January 17, 2012
Elder leaves agency after more than two decades Read More »
Published October 6, 2011
Vadodara site can now provide API manufacturing Read More »
Published August 12, 2011
To manufacture a solid dose product for a client Read More »
Published June 15, 2011
Dr. Reddy’s chemical manufacturing facility in Cuernavaca, Mexico has received a four-item Warning Letter from the FDA. Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On